Citius Pharmaceuticals Inc. Common (CTXR) is a publicly traded Healthcare sector company. As of November 11, 2026, CTXR trades at $0.50 with a market cap of $14.45M and a P/E ratio of -0.16. CTXR moved +1.06% today. Year to date, CTXR is -41.75%; over the trailing twelve months it is -61.41%. Its 52-week range spans $0.37 to $2.48. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces CTXR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CTXR, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.50 |
| Market Cap | $14.45M |
| P/E Ratio | -0.16 |
| EPS | $-3.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.48 |
| 52-Week Low | $0.37 |
| Volume | 60 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.74M |
| Gross Margin | 0.00% |
1 analysts cover CTXR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.